Price Alert

Greenwich LifeSciences In... (GLSI)

NASDAQ: GLSI · Real-Time Price · USD

12.11

0.03 (0.25%)

At close: Aug 15, 2025, 3:59 PM

12.17

0.50%

After-hours: Aug 15, 2025, 07:26 PM EDT

Greenwich LifeSciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	2.75M	4.09M	5.82M	7.22M	5.51M	6.99M	9.14M	10.94M	11.91M	13.47M	15.64M	17.19M	19.74M	27.2M	28.91M	29.8M	30.4M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	-0.00	0.00	n/a	n/a	0.00	0.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	2.68K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	2.75M	4.09M	5.83M	7.22M	5.51M	6.99M	9.14M	10.94M	11.91M	13.47M	15.64M	17.19M	19.74M	27.2M	28.91M	29.8M	30.4M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	1.78K	n/a	3.58K	4.49K	5.39K	6.29K	7.2K	8.1K	9K	9.91K	10.81K	11.71K	12.62K	13.52K	14.42K	15.32K
Total Long-Term Assets	876.00	1.78K	2.68K	3.58K	4.49K	5.39K	6.29K	7.2K	8.1K	9K	9.91K	10.81K	11.71K	12.62K	13.52K	14.42K	15.32K
Total Assets	2.75M	4.09M	5.83M	7.23M	5.51M	6.99M	9.15M	10.95M	11.92M	13.48M	15.65M	17.2M	19.75M	27.22M	28.92M	29.82M	30.42M
Account Payables	1.05M	1.18M	774.76K	1.11M	125.74K	35.47K	10.06K	79.62K	220.84K	220.84K	220.84K	220.84K	220.84K	220.84K	295.85K	627.58K	609.27K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	305.21K	382.2K	n/a	n/a	220.84K	n/a	220.84K	n/a	n/a	n/a	n/a	-220.84K	-220.84K	n/a	n/a	n/a	n/a
Total Current Liabilities	1.44M	1.56M	842.38K	1.35M	389.61K	294.41K	297.29K	301.55K	235.57K	262.9K	237.88K	229.13K	241.17K	385.17K	455.12K	652.59K	673.12K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	220.84K	220.84K	220.84K	220.84K	220.84K	220.84K	n/a	n/a	n/a
Total Liabilities	1.44M	1.56M	842.38K	1.35M	389.61K	294.41K	297.29K	301.55K	235.57K	262.9K	237.88K	229.13K	241.17K	385.17K	455.12K	652.59K	673.12K
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	13.19K	13.15K	13.14K	13.07K	12.88K	12.85K	12.85K	12.85K	12.85K	12.85K	12.85K	12.78K	12.95K	13.15K	12.99K	12.92K	12.85K
Retained Earnings	-69.41M	-66.15M	-58.11M	-55.44M	-52.84M	-50.36M	-47.62M	-45.23M	-43.6M	-41.47M	-38.68M	-36.36M	-35.62M	-33.65M	-31.29M	-30.42M	-29.67M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	0.00	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	-0.00	n/a	-0.00	-0.00
Shareholders Equity	1.31M	2.53M	4.98M	5.88M	5.12M	6.7M	8.85M	10.65M	11.68M	13.21M	15.41M	16.97M	19.51M	26.83M	28.46M	29.16M	29.75M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a